Company / CapEx per Share
Outlook Therapeutics, Inc. CapEx per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2020
5-year range
$0.01 / $0.31
FY2016-FY2020
Trend
-95.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.01 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2020 with a 3-year CAGR of -31.8%.
Improved from $0.01 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -31.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, capex per share decreased 95.0% year-over-year.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | $0.02 | -95.0% |
| FY2019 | $0.31 | +2529.9% |
| FY2018 | $0.01 | -75.7% |
| FY2017 | $0.05 | -94.8% |
| FY2016 | $0.93 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026